A carregar...
Structurally Based Design of Glucagon Mutants that Inhibit Fibril Formation
The peptide hormone glucagon is prescribed as a pharmaceutical compound to treat diabetic hypoglycemia. However, at the acidic pH where it is highly soluble, glucagon rapidly aggregates into inactive and cytotoxic amyloid fibrils. The recently determined high-resolution structure of these fibrils re...
Na minha lista:
| Publicado no: | Biochemistry |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8254510/ https://ncbi.nlm.nih.gov/pubmed/34124902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.biochem.1c00214 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|